It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2009-2010. During the financial year, The Company’s revenue was Rs. 70,277 million. The company’s overall revenue grew by 9%. Return on Capital Employed (RoCE) in 2009-10 was 17%, as against 14% in 2008-09. Adjusted EBITDA of Rs. 15,828 million is highest among pharmaceutical companies in India. Net profit of Rs. 1,068 million in 2009-10 as against a net loss of Rs. 5,168 million in 2008-09. The company’s adjusted net income increased by 10% to Rs. 9,217 million in 2009-10 from Rs. 8,355 million in 2008-09. Fully diluted earnings per share were at Rs. 6.30 in 2009-10 as against Rs. (30.69) in 2008-09.
The Board of Directors of the Company for the declaration by the shareholders for the year 2009-10 is Rs. 11.25 per share (225%) of Rs. 5/- face value. Chart 4 gives the dividend history of the Company.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
